Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS)

被引：13

作者：

Montalban-Bravo, Guillermo ^{[1
]}

Kanagal-Shamanna, Rashmi ^{[2
]}

Darbaniyan, Faezeh ^{[3
]}

Siddiqui, Maria Tariq ^{[1
]}

Sasaki, Koji ^{[1
]}

Wei, Yue ^{[1
]}

Yang, Hui ^{[1
]}

Chien, Kelly S. ^{[1
]}

Naqvi, Kiran ^{[1
]}

Jabbour, Elias ^{[1
]}

Kadia, Tapan M. ^{[1
]}

Daver, Naval ^{[1
]}

DiNardo, Courtney ^{[1
]}

Ravandi, Farhad ^{[1
]}

Pemmaraju, Naveen ^{[1
]}

Bose, Prithviraj ^{[1
]}

Verstovsek, Srdan ^{[1
]}

Pierce, Sherry ^{[1
]}

Bueso-Ramos, Carlos ^{[2
]}

Patel, Keyur ^{[2
]}

Do, Kim-Anh ^{[3
]}

Kantarjian, Hagop ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Unit 428, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 07期

关键词：

D O I：

10.1002/ajh.26182

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E246 / E249

页数：4

共 50 条

[1] Genomic and Transcriptomic Differences of Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) and Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)
Bravo, Guillermo Montalban
Kanagal-Shamanna, Rashmi
Darbaniyan, Faezeh
Ganan-Gomez, Irene
Sasaki, Koji
Naqvi, Kiran
Wei, Yue
Yang, Hui
Soltysiak, Kelly A.
Chien, Kelly S.
Bueso-Ramos, Carlos E.
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
BLOOD, 2020, 136
[2] Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)
Nicolosi, Maura
Mudireddy, Mythri
Vallapureddy, Rangit
Gangat, Naseema
Tefferi, Ayalew
Patnaik, Mrinal M.
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (01) : E27 - E30
[3] Lymphocytopenia predicts shortened survival in myelodysplastic syndrome with ring sideroblasts (MDS-RS) but not in MDS/MPN-RS-T
Mangaonkar, Abhishek A.
Farrukh, Faiqa
Reichard, Kaaren K.
Ketterling, Rhett P.
Gangat, Naseema
Al-Kali, Aref
Begna, Kebede
Pardanani, Animesh
Patnaik, Mrinal M.
Tefferi, Ayalew
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (03) : E109 - E112
[4] Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management"
Patnaik, Mrinal M.
Tefferi, Ayalew
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (03) : 379 - 394
[5] Clinical Outcomes with Hypomethylating Agents in Patients with Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T); A Case Series
Siddiqui, Maria Tariq
Kanagal-Shamanna, Rashmi
Naqvi, Kiran
Sasaki, Koji
Masarova, Lucia
Jabbour, Elias
Pemmaraju, Naveen
Kadia, Tapan M.
Ravandi, Farhad
Daver, Naval
Borthakur, Gautam
Pierce, Sherry A.
Verstovsek, Srdan
Bose, Prithviraj
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
Montalban-Bravo, Guillermo
BLOOD, 2020, 136
[6] Extramedullary myelodysplastic/myeloproliferative neoplasm (MDS/MPN) with ring sideroblasts and thrombocytosis
Kerneves, Pauline
Cornet, Edouard
Paubelle, Etienne
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (05) : 890 - 891
[7] Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)
Antelo, Guadalupe Belen
Coltro, Giacomo
Mangaonkar, Abhishek A.
Lasho, Terra
Finke, Christy
Carr, Ryan M.
Gangat, Naseema
Binder, Moritz
Al-Kali, Aref
Elliott, Michelle A.
Howard, Matthew T.
King, Rebecca L.
Hogan, William J.
Litzow, Mark
Pardanani, Animesh
Tefferi, Ayalew
Fernandez-Zapico, Martin
Patnaik, Mrinal M.
BLOOD, 2019, 134
[8] Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)
Antelo, Guadalupe
Mangaonkar, Abhishek A.
Coltro, Giacomo
Buradkar, Ajinkya
Lasho, Terra L.
Finke, Christy
Carr, Ryan
Binder, Moritz
Gangat, Naseema
Al-Kali, Aref
Elliott, Michelle A.
King, Rebecca L.
Howard, Matthew
Melody, Megan E.
Hogan, William
Litzow, Mark R.
Tefferi, Ayalew
Fernandez-Zapico, Martin E.
Komrokji, Rami
Patnaik, Mrinal M.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (03) : E104 - E108
[9] Efficacy and Safety of Luspatercept Treatment in Patients with Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T): A Retrospective Analysis from the Medalist Study
Komrokji, Rami S.
Platzbecker, Uwe
Fenaux, Pierre
Garcia-Manero, Guillermo
Mufti, Ghulam J.
Santini, Valeria
Diez-Campelo, Maria
Finelli, Carlo
Jurcic, Joseph G.
Greenberg, Peter L.
Sekeres, Mikkael A.
Zeidan, Amer M.
DeZern, Amy E.
Savona, Michael R.
Shetty, Jeevan K.
Ito, Rodrigo
Zhang, George
Ha, Xianwei
Sinsimer, Daniel
Backstrom, Jay T.
Verma, Amit
BLOOD, 2020, 136
[10] Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients
Mangaonkar, Abhishek A.
Lasho, Terra L.
Ketterling, Rhett P.
Reichard, Kaaren K.
Gangat, Naseema
Al-Kali, Aref
Begna, Kebede H.
Pardanani, Animesh
Al Ali, Najla H.
Talati, Chetasi
Sallman, David
Padron, Eric
Patnaik, Mrinal M.
Tefferi, Ayalew
Komrokji, Rami
BLOOD CANCER JOURNAL, 2022, 12 (02)

← 1 2 3 4 5 →